Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe "golden dose" of Mounjaro refers to the 15 mg strength — the highest available in the UK and the dose used in the SURMOUNT-1 trial, where participants lost an average of around 20–21% of their body weight over 72 weeks, as published in the New England Journal of Medicine. Each 15 mg Mounjaro KwikPen contains four weekly doses at that strength. Reaching it is a clinical decision, not a consumer choice: Mounjaro is a Prescription-Only Medicine under UK law, and a prescriber determines whether and when a patient moves to that dose based on tolerability and clinical response. Private prices for the 15 mg pen vary across providers. Eli Lilly raised UK list prices significantly from 1 September 2025, and typical private prices for the highest strength have since been reported in the region of £300–£375 per pen, though figures differ by provider and should be verified directly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The evidence that earned 15 mg its informal reputation comes from SURMOUNT-1, which randomised 2,539 adults with obesity across multiple tirzepatide doses. At 15 mg over 72 weeks, average weight loss reached approximately 20–21%, with some analyses reaching around 22.5%, figures that NICE's appraisal of tirzepatide (TA1026) took into account when recommending the medicine. Those results didn't come from starting at 15 mg. The licensed schedule begins at 2.5 mg (a tolerability step whose job is to settle the GI system, not to produce the numbers the trial reported) and climbs in stages the prescriber controls. How quickly someone reaches 15 mg, or whether they reach it at all, depends on how they tolerate each step and what their prescriber judges appropriate. Pricing reflects this: if you want to understand how much the Mounjaro pen costs at each strength, the 15 mg commands a higher market price than lower strengths, which is relevant when budgeting for treatment over several months.
It is also worth knowing that the Mounjaro KwikPen at any strength contains four pre-filled weekly doses in a single device. One pen covers a full four-week period, so per-pen pricing maps directly onto monthly cost.
Since Eli Lilly's September 2025 list-price revision, the 15 mg pen's market list price rose to around £330, and private provider prices have generally been reported in the range of £300–£375. Those figures are widely cited but worth treating as a starting point rather than a final number, because what a headline price includes varies considerably. Some providers charge separately for the initial consultation, the prescription itself, or ongoing clinical oversight. Delivery may be added at checkout. Aftercare (advice on side effects, guidance if a dose-change is needed, clinical review before a repeat prescription is issued) is sometimes bundled and sometimes charged extra or not offered at all.
For a medicine that requires prescriber involvement before every supply, those extras aren't optional. They are the clinical infrastructure that makes treatment safe. Our full Mounjaro price guide sets out what legitimate private pricing typically includes and how to read a quote accurately.
One transparent price at nume covers consultation, prescription, treatment and free next-working-day delivery. Our clinical team's current pricing is shown on the treatment page. We don't print per-pen prices in editorial copy, and we don't run discount codes, vouchers or promotional offers. That's a deliberate position. A GLP-1 prescription medicine sold at a steep discount should prompt a question, not a click, and the MHRA has been unambiguous about the risk of pens sold without proper clinical oversight, including fake products that have been found to contain insulin rather than tirzepatide. Reporting a suspect seller goes through the MHRA's Yellow Card scheme.
Cheapest isn't the right measure for a prescription medicine. The right measure is whether treatment is genuine, clinically supervised and properly supplied. We don't win a race to the lowest price on purpose, because the infrastructure behind a safe, monitored prescription is what a patient at 15 mg of tirzepatide actually needs. If you'd like to check your eligibility and talk to our prescribers, start your free consultation.
For broader context on Mounjaro as a treatment, our Mounjaro overview covers the clinical evidence, how the medicine works and what to expect across the dosing journey. Questions about how much each dose of Mounjaro costs across the range can be found via our breakdown of what one dose of Mounjaro costs.
At the price point the 15 mg pen commands, the temptation to find a cheaper alternative online is understandable. The practical safeguard is simple: check that any pharmacy you buy from appears on the GPhC's pharmacy register before placing an order. No GPhC registration, no legitimate prescription chain. Sellers offering these medicines without a prescription, through social media, or at prices substantially below the market range are red flags identified by the MHRA as characteristic of counterfeit supply.
What arrives from a GPhC-registered pharmacy should be traceable from source: the pen in its manufacturer's packaging, a DPD tracking notification on your phone, a plain unbranded outer box. That detail matters at any dose, and particularly at the highest one, where a genuine 15 mg KwikPen contains a medicine that took months of titration to reach. Our clinical team includes GPhC-registered Independent Prescribers who review every consultation personally. You can verify our pharmacy registration directly at the GPhC register (premises number 9012878). Further questions can be directed to our FAQs or our support team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.